Screener
Vera Therapeutics VERA Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Vera Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212143
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $114,351 | $354,725 |
| Marketable securities | 482,409 | 359,864 |
| Prepaid expenses and other assets, current | 19,042 | 14,294 |
| Total current assets | 615,802 | 728,883 |
| Other assets, noncurrent | 5,937 | 5,850 |
| Total assets | $621,739 | $734,733 |
| Liabilities and stockholders’ equity |
Item 1. Financial Statements
FAQ
- What is Vera Therapeutics's prepaid & other current?
- Vera Therapeutics (VERA) reported prepaid & other current of $19.04M in Q1 2026.
- How has Vera Therapeutics's prepaid & other current changed year-over-year?
- Vera Therapeutics's prepaid & other current increased by 17.2% year-over-year, from $16.24M to $19.04M.
- What is the long-term trend for Vera Therapeutics's prepaid & other current?
- Over 4 years (2021 to 2025), Vera Therapeutics's prepaid & other current has grown at a 47.1% compound annual growth rate (CAGR), from $12.61M to $58.99M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Vera Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude